HSP90AA1 and pancreatic neoplasm: Sulforaphane was also recently shown to modify Hsp90 in vitro and to disrupt the interaction between Hsp90 and its co-chaperone Cdc37 and cause degradation of Hsp90 client proteins in pancreatic cancer cells [186].